FDA Inspection 1230600 — The American National Red Cross

The American National Red Cross — FEI 2173038

The FDA completed an inspection of The American National Red Cross on February 28, 2024 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Saint Paul, MN (United States)